Caravel Bio is building the first limitless protein evolution platform, creating proteins that exceed nature’s bounds to make powerful catalysts and therapeutics. Today, the bounds of protein engineering are defined by the organisms in which proteins are expressed. Caravel surpasses this limitation by enabling high-throughput evolution of cell-free, in vitro, systems. This new capability is enabled by innovations in microfluidics, cell-free protein synthesis, and bacterial spore-display. We’re using our platform to create long-lasting enzymes for carbon capture and enabling precision manufacturing of proteins with new chemistries using genetic code expansion.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Portland, Or 97239, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.caravel.bio
- HQ
- Portland, OR
Caravel Bio Questions
Caravel Bio's website is https://www.caravel.bio
Caravel Bio's LinkedIn profile is https://www.linkedin.com/company/caravel-bio
Caravel Bio has
5 employees.
View email and phone details for 5
employees at Caravel Bio.
Caravel Bio's industry is
Biotechnology Research
Caravel Bio's top competitors are
Daicel Arbor Biosciences,
Aminoverse,
Enginzyme,
Zymergen,
Cascade Bio,
Rubi Laboratories,
Keliomics,
Allozymes,
Exozymes (Nasdaq: Exoz),
Tierra Biosciences.
Caravel Bio's categories are Biotechnology Research
Caravel Bio's founding year is 2022
